Zobrazeno 1 - 10
of 69
pro vyhledávání: '"Taijyu, Satoh"'
Autor:
Hideaki Suzuki, Takumi Inoue, Yousuke Terui, Kouki Takeuchi, Kai Susukita, Marina Arai, Haruka Sato, Taijyu Satoh, Saori Yamamoto, Nobuhiro Yaoita, Shunsuke Tatebe, Hideka Hayashi, Kotaro Nochioka, Hiroyuki Takahama, Satoshi Yasuda
Publikováno v:
ESC Heart Failure, Vol 11, Iss 4, Pp 2451-2454 (2024)
Abstract Aims Vericiguat has been used to treat patients with heart failure with reduced ejection fraction (HFrEF) who demonstrated worsening heart failure despite treatment with other guideline‐directed medical therapies. The haemodynamic effects
Externí odkaz:
https://doaj.org/article/876d86b382c345a7895d729ec370ee5d
Autor:
Taijyu Satoh, Nobuhiro Yaoita, Kotaro Nochioka, Shunsuke Tatebe, Hideka Hayashi, Saori Yamamoto, Haruka Sato, Hiroyuki Takahama, Hideaki Suzuki, Yosuke Terui, Kaito Yamada, Yusuke Yamada, Takumi Inoue, Tatsuo Aoki, Kimio Satoh, Koichiro Sugimura, Satoshi Miyata, Satoshi Yasuda
Publikováno v:
ESC Heart Failure, Vol 10, Iss 6, Pp 3592-3603 (2023)
Abstract Aims The pathophysiology of pulmonary hypertension (PH) due to left‐sided heart disease (Group 2 PH) is distinct from that of other groups of PH, yet there are still no approved therapies that selectively target pulmonary circulation. The
Externí odkaz:
https://doaj.org/article/a8047feefc1a47d7b27517b4a0a6459e
Autor:
Yosuke Terui, Hideaki Suzuki, Akio Chikata, Yuichi Hanaki, Yuki Komatsu, Hideki Ota, Fumiyoshi Fujishima, Rei Umezawa, Kota Ouchi, Haruka Sato, Taijyu Satoh, Saori Miyamichi-Yamamoto, Nobuhiro Yaoita, Hideka Hayashi, Kotaro Nochioka, Hiroyuki Takahama, Akihiko Nogami, Yoshikatsu Saiki, Satoshi Yasuda
Publikováno v:
Internal Medicine; 2024, Vol. 63 Issue 12, p1725-1731, 7p
Autor:
Nobuhiro Yaoita, Kimio Satoh, Taijyu Satoh, Toru Shimizu, Sakae Saito, Koichiro Sugimura, Shunsuke Tatebe, Saori Yamamoto, Tatsuo Aoki, Nobuhiro Kikuchi, Ryo Kurosawa, Satoshi Miyata, Masao Nagasaki, Jun Yasuda, Hiroaki Shimokawa
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 9, Iss 21 (2020)
Background Although chronic thromboembolic pulmonary hypertension (CTEPH) and acute pulmonary embolism (APE) share some clinical manifestations, a limited proportion of patients with CTEPH have a history of APE. Moreover, in histopathologic studies,
Externí odkaz:
https://doaj.org/article/179851efe4a5413b9aff466873985b6c
Autor:
Tomohiro Ohtsuki, Kimio Satoh, Toru Shimizu, Shohei Ikeda, Nobuhiro Kikuchi, Taijyu Satoh, Ryo Kurosawa, Masamichi Nogi, Shinichiro Sunamura, Nobuhiro Yaoita, Junichi Omura, Tatsuo Aoki, Shunsuke Tatebe, Koichiro Sugimura, Jun Takahashi, Satoshi Miyata, Hiroaki Shimokawa
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 8, Iss 23 (2019)
Background Circulating proteins are exposed to vascular endothelial layer and influence their functions. Among them, adipsin is a member of the trypsin family of peptidases and is mainly secreted from adipocytes, monocytes, and macrophages, catalyzin
Externí odkaz:
https://doaj.org/article/facf05007d0043f8af15ebbce81c047b
Autor:
Scott A. Hahn, Ying Tang, Mark T. Gladwin, Taijyu Satoh, Charles F. McTiernan, Kentaro Noda, Cynthia St. Hilaire, Bing Wang, Adam C. Straub, Samuel K. Wyman, Cristina Espinosa-Diez, Georgios Triantafyllou, Jeffrey J. Baust, Sruti Shiva, Matthew R Dent, Longfei Wang, Yijen L. Wu, Elena A. Goncharova, Dmitry A. Goncharov, Mike Reynolds, Yen Chun Lai, Andrea R. Levine, Elizabeth R. Rochon, Delphine Gomez, Stephen Y. Chan
Publikováno v:
Circulation
Circulation, vol 144, iss 8
Circulation, vol 144, iss 8
Background: Many patients with heart failure with preserved ejection fraction have metabolic syndrome and develop exercise-induced pulmonary hypertension (EIPH). Increases in pulmonary vascular resistance in patients with heart failure with preserved
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::18dd19792af0a24361cc927770ec42bd
https://doi.org/10.1161/circulationaha.121.053889
https://doi.org/10.1161/circulationaha.121.053889
Autor:
Masanobu Miura, Tatsuo Aoki, Nobuhiro Yaoita, Taijyu Satoh, Koichiro Sugimura, Katsuya Kozu, Saori Yamamoto, Hideaki Suzuki, Kotaro Nochioka, Yosuke Terui, Kimio Satoh, Ryo Konno, Toru Shimizu, Haruka Sato, Hiroaki Shimokawa, Satoshi Miyata, Nobuhiro Kikuchi, Shunsuke Tatebe
Publikováno v:
Journal of Cardiology. 75:415-423
Although cardiac troponin and natriuretic peptide have been shown to decrease after balloon pulmonary angioplasty (BPA) with improved right ventricular afterload in chronic thromboembolic pulmonary hypertension (CTEPH), biomarkers to evaluate the eff
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f743c1fcd4c9c9a477b8e10970e21a4c
https://doi.org/10.1016/j.jjcc.2019.09.010
https://doi.org/10.1016/j.jjcc.2019.09.010
Autor:
Satoshi Higuchi, Hideki Ota, Nobuhiro Yaoita, Hiroki Kamada, Hidenobu Takagi, Taijyu Satoh, Satoshi Yasuda, Kei Takase
Publikováno v:
Journal of cardiology.
Chronic thromboembolic pulmonary hypertension (CTEPH), classified as group 4 pulmonary hypertension (PH), is caused by stenosis and obstruction of the pulmonary arteries by organized thrombi that are incompletely resolved after acute pulmonary emboli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::69ede00dbbd99304489ddd1e33f67ddd
https://pubmed.ncbi.nlm.nih.gov/35490106
https://pubmed.ncbi.nlm.nih.gov/35490106
Autor:
Georgios Triantafyllou, Taijyu Satoh, Charles F MCTIERNAN, Sruti Shiva, Adam C Straub, Mark T Gladwin
Publikováno v:
Circulation. 144
Introduction: Exercise induced pulmonary hypertension (EIPH) portends worse prognosis compared to isolated resting PH. Exercise increases mitochondrial reactive oxygen species (mROS) production in peripheral blood mononuclear cells of patients with h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7d6fe03bfae2122b58d3a57f6c0d180b
https://doi.org/10.1161/circ.144.suppl_1.12968
https://doi.org/10.1161/circ.144.suppl_1.12968
Autor:
Maryam Sharifi-Sanjani, Andres Pulgarin, Ying Tang, Sébastien Bonnet, John Sembrat, Patricia Forsythe, Annie M. Watson, Imad Al Ghouleh, Miranda K. Culley, Bridget K. Wagner, Thomas Bertero, Vinny Negi, Seungchan Kim, Qiujun Yu, Jimin Yang, Xianglin Yin, Yassmin Al Aaraj, Anastasia Gorelova, Taijyu Satoh, Stéphanie Torrino, Arun Rajaratnam, Jingsi Zhao, Stephen Y. Chan, Stuart L. Schreiber, Gil Speyer, Mauricio Rojas, Sara O. Vargas, Mingji Dai, Steeve Provencher, Adam Handen, Yi Yin Tai
Publikováno v:
Science Advances
Description
A network dependency platform was generated to define a landscape of cancer drug mechanisms in pulmonary hypertension.
Cancer therapies are being considered for treating rare noncancerous diseases like pulmonary hypertension (PH
A network dependency platform was generated to define a landscape of cancer drug mechanisms in pulmonary hypertension.
Cancer therapies are being considered for treating rare noncancerous diseases like pulmonary hypertension (PH
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c1721684f9c583fd65565e41c603b50d
https://pubmed.ncbi.nlm.nih.gov/34669463
https://pubmed.ncbi.nlm.nih.gov/34669463